Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

Purpose: Standard chemoradiation therapy for stage III non-small cell lung cancer (NSCLCa) results in suboptimal outcomes with a high rate of local failure and poor overall survival. We hypothesize that dose escalation using stereotactic body radiotherapy (SBRT) boost could improve upon these result...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hepel, Jaroslaw T., Peter, Justin, Hiatt, Jessica R., Patel, Salil, Osibanjo, Oluwademilade, Safran, Howard, Curran, Bruce, DiPetrillo, Thomas
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Research Foundation 2012
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3458262/
https://ncbi.nlm.nih.gov/pubmed/23057009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00124
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items